Premium
Imatinib mesylate lacks activity in small cell lung carcinoma expressing c‐kit protein: A phase II clinical trial
Author(s) -
Altundag Ozden,
Altundag Kadri,
Boruban Cem,
Silay Yavuz S.,
Turen Selahattin
Publication year - 2005
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.21407
Subject(s) - imatinib , medicine , autocrine signalling , imatinib mesylate , paracrine signalling , cancer research , population , oncology , surgical oncology , chemotherapy , carcinoma , receptor , environmental health , myeloid leukemia
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom